27 Results for "

marmoset

" in MedChemExpress (MCE) Product Catalog:
Products (27)

27 Results for "marmoset" in MCE Product Catalog:

12
12 Cited Publications
Cat. No.: HY-15498
CAS No.: 1289023-67-1
Purity:  99.94%
Synonyms: BMS-927711; BHV-3000
Target:  

CGRP Receptor

Research Areas:  

Neurological Disease

Rimegepant (BMS-927711; BHV-3000) is an orally bioavailable and blood-brain barrier permeable antagonist of CGRP and AMY1 receptors, with a pIC50 of 8.01 and a Ki of 0.027 nM for human CGRP receptors. Rimegepant antagonizes cAMP production induced by αCGRP, βCGRP and amylin at CGRP and AMY1 receptors in humans, rats and mice, as well as at rat AMY3 receptors. Rimegepant can be used in research related to migraine .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-108810
CAS No.: 914613-48-2
Purity:  99.64%
Synonyms: Ilaris; ACZ 885
Canakinumab (ACZ885) is a recombinant human anti-IL-1β monoclonal antibody. Canakinumab shows IC50 values of 43.6 and 40.8 pM for human and marmoset IL-1β, respectively. The mode of action of canakinumab is based on the neutralization of IL-1β signaling, resulting in suppression of inflammation related to disorders of autoimmune origin .
loading...
    loading...
Cat. No.: HY-121314
CAS No.: 40665-92-7
Research Areas:  

Metabolic Disease

Cloprostenol is a prostaglandin F-2α (PGF2α (HY-12956)) analogue. Cloprostenol induces luteolysis in marmoset monkeys. Cloprostenol can be used for the research of open-cervix pyometra .
loading...
    loading...
Cat. No.: HY-118956
CAS No.: 166591-11-3
Purity:  98.01%
Synonyms: ABT-431 hydrochloride; DAS-431 hydrochloride
Target:  

Dopamine Receptor

Research Areas:  

Neurological Disease

Adrogolide hydrochloride (ABT-431 hydrochloride) is a chemically stable prodrug that can convert to the dopamine D1 receptor agonist A-86929. Adrogolide hydrochloride ameliorates the MPTP (HY-15608)-induced Parkinson's Disease in marmoset model, reduces the dyskinesias tendency. Adrogolide hydrochloride reverses Risperidone (HY-11018)-induced cognitive deficits in monkey .
loading...
    loading...
Cat. No.: HY-P4990
CAS No.: 24327-19-3
Target:  

Oxytocin Receptor

Research Areas:  

Endocrinology

Pro8-Oxytocin is a a modified oxytocin (OXT) ligand. Pro8-Oxytocin produces more potent and efficacious responses at primate OXTR and stronger behavioral effects than the consensus mammalian OXT ligand (Leu8-Oxytocin). Pro8-Oxytocin produce a less efficacious response than Vasopressin (HY-B1811) (AVP) at human AVPR1a and higher efficacious response than AVP at marmoset AVPR1a .
loading...
    loading...
Cat. No.: HY-P991611
CAS No.: 3058434-76-4

Target:  

iGluR

Research Areas:  

Inflammation/Immunology

ART5803 is a humanized IgG1 monoclonal antibody inhibitor targeting NMDAR. ART5803 binds to the N-terminal domain (NTD) of the NMDAR GluN1 subunit (GluN1-NTD) with a high affinity. ART5803 blocks NMDAR internalization induced by pathogenic autoantibodies and restores cell-surface NMDAR expression and functions. ART5803 reverses behavioral abnormalities and NMDAR expression in marmoset disease models. ABT-147 can be used to study anti-NMDAR encephalitis .
loading...
    loading...
Cat. No.: HY-P4990A
Target:  

Oxytocin Receptor

Research Areas:  

Endocrinology

Pro8-Oxytocin TFA is a a modified oxytocin (OXT) ligand. Pro8-Oxytocin produces more potent and efficacious responses at primate OXTR and stronger behavioral effects than the consensus mammalian OXT ligand (Leu8-Oxytocin). Pro8-Oxytocin TFA produce a less efficacious response than Vasopressin (HY-B1811) (AVP) at human AVPR1a and higher efficacious response than AVP at marmoset AVPR1a .
loading...
    loading...
Cat. No.: HY-156701
CAS No.: 1428988-21-9
Research Areas:  

Metabolic Disease Endocrinology

BAY-1128688 is a potent, orally active and selective AKR1C3 inhibitor with IC50 < 2 nM. BAY-1128688 shows high selectivity over related AKR1C enzymes (1C1, 1C2, 1C4) and AKR1D1. BAY-1128688 exhibits no relevant activity at major nuclear hormone receptors. BAY-1128688 reduces endometriotic lesions in the marmoset monkey endometriosis model. BAY-1128688 can be used for endometriosis research .
loading...
    loading...
Cat. No.: HY-A0184
CAS No.: 126222-34-2
Synonyms: Ro 42-5892; Ro 42-5892/001
Target:  

Renin

Research Areas:  

Cardiovascular Disease

Remikiren (Ro 42-5892) is an orally active and highly specific renin inhibitor. Remikiren specifically inhibits human reninand human plasma renin with IC50 values of 0.7 and 0.8 nM, respectively. Remikiren also reduces mean arterial blood pressure in sodium-depleted marmosets and squirrel monkeys. Remikiren can be used in study of hypertension .
loading...
    loading...
Cat. No.: HY-125625
CAS No.: 116326-39-7
Target:  

Renin

Research Areas:  

Cardiovascular Disease

ES 6864 is an orally active, competitive inhibitor for human renin, with an IC50 of 6.9 nM and a Ki of 7.3 nM. ES 6864 exhibits high species-specific and enzyme-specific properties. ES 6864 exhibits metabolic stability in rat tissue homogenates. ES 6864 reduces blood pressure in rats and sodium-depleted awake marmosets .
loading...
    loading...
Cat. No.: HY-100299A
CAS No.: 190841-57-7
RPR107393 is an orally active potent selective squalene synthase (SQS) inhibitor. RPR107393 inhibits rat liver microsomal squalene synthase with an IC50 value of 0.8 nM. RPR107393 reduces triglyceride biosynthesis by suppressing fatty acid biosynthesis via an increase in intracellular farnesol and its derivatives. RPR107393 reduces plasma cholesterol in rats and marmosets. RPR107393 can be used for metabolic disease research, such as hypercholesterolemia, hypertriglyceridemia and atherosclerosis .
loading...
    loading...
Cat. No.: HY-100299
CAS No.: 197576-78-6
RPR107393 free base is an orally active potent selective squalene synthase (SQS) inhibitor. RPR107393 free base inhibits rat liver microsomal squalene synthase with an IC50 value of 0.8 nM. RPR107393 free base reduces triglyceride biosynthesis by suppressing fatty acid biosynthesis via an increase in intracellular farnesol and its derivatives. RPR107393 free base reduces plasma cholesterol in rats and marmosets. RPR107393 free base can be used for metabolic disease research, such as hypercholesterolemia, hypertriglyceridemia and atherosclerosis [1][2].
loading...
    loading...
Cat. No.: HY-163452
Target:  

Farnesyl Transferase

Research Areas:  

Metabolic Disease

Squalene synthase-IN-2 (comppund isomer A-(1S, 3R)-14i) is an orally active squalene synthase inhibitor with IC50 values of 3.4, 99 nM for squalene synthase and cholesterol synthesis, respectively. Squalene synthase-IN-2 reduces plasma cholesterol and triglyceride .
loading...
    loading...
Cat. No.: HY-P991445

Target:  

SARS-CoV

Research Areas:  

Infection

REGN3051 is a human IgG1 monoclonal antibody (mAb) targeting MERS CoV. REGN3051 reduces viral titers in the lungs of mice expressing human DPP4. REGN3051 decreases lung disease severity and viral replication in marmosets inoculated with MERS-CoV. Recommended isotype control: Human IgG1 kappa, Isotype Control (HY-P99001) .
loading...
    loading...
Cat. No.: HY-120206
CAS No.: 171655-91-7
Synonyms: BMS-204756
Target:  

Monoamine Oxidase

Research Areas:  

Neurological Disease

Brasofensine (BMS-204756) is an oral active dopamine transporter antagonist and can be used for parkinson’s disease research .
loading...
    loading...
Cat. No.: HY-120206B
CAS No.: 171655-92-8
Synonyms: BMS-204756 sulfate
Target:  

Monoamine Oxidase

Research Areas:  

Neurological Disease

Brasofensine (BMS-204756) sulfate is an oral active dopamine transporter antagonist and can be used for parkinson’s disease research .
loading...
    loading...
Cat. No.: HY-121550
CAS No.: 139958-16-0
ME3221 is an angiotensin AT1 receptor antagonist that effectively antagonizes the pressor response to angiotensin II in rats and marmosets without affecting the hypotensive response to bradykinin. It demonstrates potent antihypertensive effects in renal hypertensive rats and spontaneously hypertensive rats (SHR). ME3221's repeated administration in SHR results in sustained and stable hypotensive effects without affecting heart rate, indicating its potential for studying both renal and essential hypertension .
loading...
    loading...
Cat. No.: HY-171472
CAS No.: 171961-95-8
Target:  

Dopamine Receptor

Research Areas:  

Neurological Disease

A-86929 is a highly potent and selective dopamine D1 receptor agonist with a pKi value of 7.3. In the 6-OHDA (HY-B1081)-induced unilateral nigrostriatal lesion rat model, A-86929 significantly induces rotational behavior. It also improves motor function in the MPTP (HY-15608)-induced Parkinson's disease marmoset model. Additionally, A-86929 demonstrates potential therapeutic value in reducing cocaine-seeking behavior in rats and reversing Haloperidol (HY-14538)-induced cognitive deficits in rhesus monkeys. A-86929 can be used for research in neurological disorders .
loading...
    loading...
Cat. No.: HY-120206A
CAS No.: 173830-14-3
Synonyms: BMS-204756 maleate
Target:  

Monoamine Oxidase

Research Areas:  

Neurological Disease

Brasofensine maleate(BMS-204756) sulfate is an oral active dopamine transporter antagonist and can be used for parkinson’s disease research .
loading...
    loading...
Cat. No.: HY-P78656
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: LAG3; Lymphocyte-Activation Gene 3; Lymphocyte Activating 3; CD223 Antigen; CD223; LAG-3; Lymphocyte Activation Gene 3 Protein; FDC
Species:  
Source:  
loading...
    loading...